These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16304247)
61. How long a stay in the hospital is needed for patients with community-acquired pneumonia? Siegel RE Am J Med; 2000 Oct; 109(5):434-6. PubMed ID: 11020402 [No Abstract] [Full Text] [Related]
62. Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? Carugati M; Aliberti S; Franzetti F Arch Intern Med; 2012 Dec; 172(22):1771; author reply 1772. PubMed ID: 23229946 [No Abstract] [Full Text] [Related]
63. Aging lung and possible animal models. Teramoto S; Ouchi Y Chest; 1999 Oct; 116(4):1145-6. PubMed ID: 10531590 [No Abstract] [Full Text] [Related]
64. Putting a critical pathway into practice: the devil is in the implementation details. Sharpe BA Arch Intern Med; 2012 Jun; 172(12):928-9. PubMed ID: 22732748 [No Abstract] [Full Text] [Related]
65. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. Samsa GP; Matchar DB; Harnett J; Wilson J Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269 [TBL] [Abstract][Full Text] [Related]
66. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. Rapp RP Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590 [TBL] [Abstract][Full Text] [Related]
67. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia. Friedman H; Song X; Crespi S; Navaratnam P Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010 [TBL] [Abstract][Full Text] [Related]
68. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997 [TBL] [Abstract][Full Text] [Related]
69. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related]
70. What's in a day? Milbrandt EB; Angus DC Chest; 2005 Nov; 128(5):3091-3. PubMed ID: 16304247 [No Abstract] [Full Text] [Related]